Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-069753

Chief Scientific Officer sold 150,000 shares at an average $19.01 ($2,851,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Reich Kristian Chief Scientific Officer 2026-06-15 Sale 10b5-1 −50,000 $18.89 $944,500 2,924,551 I
Reich Kristian Chief Scientific Officer 2026-06-16 Sale 10b5-1 −50,000 $18.70 $935,000 2,874,551 I
Reich Kristian Chief Scientific Officer 2026-06-17 Sale 10b5-1 −50,000 $19.43 $971,500 2,824,551 I
Open-market sales · 150,000 sh · avg $19.01 · $2,851,000
Loading xslF345X06/ownership.xml…